Podcast

Pharmacy Focus: Psychedelic Pharmacy - An Exploration of Psychedelic Medicines in Palliative Care

For patients facing end-of-life care, psychedelic medicines may offer a chance to feel connected with themselves and others during such a difficult time.

This month, we spoke with Paul Thielking, MD, who has been investigating the use of psychedelic medicines in palliative care environments. For patients facing end-of-life care, Thielking said psychedelic medicines may offer a chance to feel connected with themselves and others during such a difficult time.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Hematology -- Image credit: DIgilife | stock.adobe.com
Cardiovascular disease doctor or cardiologist holding red heart in clinic or hospital exam room office for csr professional medical service, cardiology health care and world heart health day concept - Image credit: Chinnapong | stock.adobe.com
Image credit: AwieDarwis | stock.adobe.com
Image credit: viperagp | stock.adobe.com
Inflammation concept, inflammated human tissues 3d rendering - Image credit: picture-waterfall | stock.adobe.com
Related Content
Breast cancer cells | Image Credit: © sknab - stock.adobe.com
July 11th 2025

Dalpiciclib Plus Endocrine Therapy Prolonged Invasive Disease-Free Survival in HR+/HER2– Breast Cancer

Alexandra Gerlach, Associate Editor
Pharmacy Focus: Importance of Mental Health for Patients and Pharmacists Alike
July 10th 2025

Pharmacy Focus: Importance of Mental Health for Patients and Pharmacists Alike

Gustavo Alva, MD Luke Halpern, Assistant Editor
ATOPP 2025: Kirollos S. Hanna, PharmD, BCPS, BCOP, FACCC, FAPO, Highlights Must-See Sessions
July 9th 2025

ATOPP 2025: Kirollos S. Hanna, PharmD, BCPS, BCOP, FACCC, FAPO, Highlights Must-See Sessions

Kirollos S. Hanna, PharmD, BCPS, BCOP, FACCC, FAPO Alana Hippensteele, Lead Editor
An Overview of Intravenous Iron in Heart Failure and the FAIR-HF2 Trial
July 1st 2025

An Overview of Intravenous Iron in Heart Failure and the FAIR-HF2 Trial

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor
Steroids -- Image credit: Cozyta | stock.adobe.com
July 9th 2025

Steroid Use During ICI Treatment Lessens Effectiveness in Patients With NSCLC

Gillian McGovern, Associate Editor
Visualization of plasma cell in multiple myeloma | Image Credit: © ArtificialHorizons - stock.adobe.com
July 8th 2025

Isa-KRD Induction Achieves 95% Response Rate in Multiple Myeloma

Alexandra Gerlach, Associate Editor